AULT INC Filed by BEL FUSE INC /NJ

Similar documents
Pharma-Bio Serv, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C BARNES & NOBLE, INC.

24889/1 07/19/ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D Under the Securities Exchange Act of

VORNADO REALTY TRUST Filed by INTERSTATE PROPERTIES

Tower Semiconductor Ltd. (Name of Issuer)

SCHEDULE 13D (Rule 13d-101)

PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC

MORGAN EQUITIES GROUP, INC. Filed by LOEVNER ROBERT B.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Alliqua BioMedical, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Under the Securities Exchange Act of 1934 (Amendment No.

GOPHER PROTOCOL INC. Filed by FLEMING STEPHEN M.

Enzymotec Ltd. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Amendment No. 1) Under the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C SCHEDULE 13D. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13D (RULE 13D - 101)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Under the Securities Exchange Act of 1934 (Amendment No.

NICE SYSTEMS LTD Filed by PSAGOT INVESTMENT HOUSE LTD.

GENCO SHIPPING & TRADING LTD Filed by AURELIUS CAPITAL MANAGEMENT, LP

Sapiens International Corporation N.V. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.

NEVADA GOLD & CASINOS INC Filed by HABERKORN STEPHEN J

SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Nemus Bioscience, Inc. (Name of Issuer)

KINGSTONE COMPANIES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

INTERNATIONAL WIRE GROUP INC Filed by BLACKSTONE DISTRESSED SECURITIES ADVISORS LP

Rose Rock Midstream, L.P. (Name of Issuer)

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

MACQUARIE INFRASTRUCTURE CORP Filed by MACQUARIE INFRASTRUCTURE MANAGEMENT (USA) INC

PRINCIPAL FINANCIAL GROUP INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

GENCO SHIPPING & TRADING LTD Filed by OZ MANAGEMENT LP

Blackstone Real Estate Income Trust, Inc.

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D/A

COMCAST CORP Filed by MICROSOFT CORP

SECURITIES AND EXCHANGE COMMISSION FORM SC 13D/A. Filing Date: SEC Accession No (HTML Version on secdatabase.

GLOBUS MEDICAL INC Filed by PAUL DAVID C

LEXINGTON REALTY TRUST Filed by VORNADO REALTY TRUST

OWENS CORNING Filed by OWENS CORNING/FIBREBOARD ASBESTOS PERSONAL INJURY TRUST

LEAR CORP Filed by ICAHN CARL C

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

GROUPON, INC. Filed by KEYWELL BRADLEY A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.

NEWS CORP Filed by SAUD H R H PRINCE ALWALEED BIN TALAL BIN ABDULAZIZ AL

ARC Group Worldwide, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101) [Missing Graphic Reference]

XILINX INC Filed by VANGUARD GROUP INC

Fiesta Restaurant Group, Inc. (Name of Issuer)

LIVEDGAR Information Provided By: GSI ONLINE A division of Global Securities Information, Inc.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

STRAIGHT PATH COMMUNICATIONS INC. Filed by MILLER LLOYD I III

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. HCI Group, Inc. Form: SC 13G/A. Date Filed:

CENTERPOINT ENERGY INC Filed by VANGUARD GROUP INC

AON PLC Filed by CAPITAL RESEARCH & MANAGEMENT CO

InfraREIT, Inc. (Name of Issuer)

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

National American University Holdings, Inc.

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Limbach Holdings, Inc (Name of Issuer)

Spark Therapeutics, Inc.

INFORMATION TO BE IN INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)

EATON CORP PLC Filed by WELLINGTON MANAGEMENT CO LLP

CASTLE BRANDS INC Filed by CAMULOS CAPITAL LP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13D

WASTE MANAGEMENT INC Filed by VANGUARD GROUP INC

HAWK SYSTEMS, INC. Filed by GREYSTONE BUSINESS CREDIT II, L.L.C.

EXFO INC. FORM SC 13G/A. (Amended Statement of Ownership) Filed 01/19/12

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

PURE BIOSCIENCE, INC. Filed by OKUNO DALE

FISERV INC Filed by BLACKROCK INC.

Realogy Holdings Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

NovoCure Limited (Name of Issuer)

SCHEDULE 13G. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Under the Securities Exchange Act of (Amendment No.

ROCKWELL COLLINS INC Filed by VANGUARD GROUP INC

DANAOS CORPORATION (Name of Issuer)

ST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

RESTATED CERTIFICATE OF INCORPORATION OF BEL FUSE INC. Dated: August 10, 1998

DIAMOND RESORTS INTERNATIONAL, INC. Filed by GUGGENHEIM CAPITAL LLC

Washington, D.C SCHEDULE 13D/A Under the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G T100 (CUSIP Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SUNOPTA INC. Filed by GRUBER & MCBAINE CAPITAL MANAGEMENT LLC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

ACCESS INTEGRATED TECHNOLOGIES INC

/d a_13d-a3...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Ecology & Environment, Inc.

SECURITIES AND EXCHANGE COMMISSION FORM SC 13G. Filing Date: SEC Accession No (HTML Version on secdatabase.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Under the Securities Exchange Act of ADMA Biologics, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.

3M CO Filed by BLACKROCK INC.

KAYNE ANDERSON MIDSTREAM ENERGY FUND, INC. (Name of Issuer)

Twilio, Inc. (Name of Issuer)

Transcription:

AULT INC Filed by BEL FUSE INC /NJ FORM SC 13D (Statement of Beneficial Ownership) Filed 09/13/99 Address 7105 NORTHLAND TERRACE MINNEAPOLIS, MN 55428-1028 Telephone 6125921900 CIK 0000723639 SIC Code 3677 - Electronic Coils, Transformers, and Other Inductors Industry Electronic Instr. & Controls Sector Technology Fiscal Year 05/30 http://www.edgar-online.com Copyright 2011, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 AULT INCORPORATED (Name of Issuer) Common Stock, no par value per share (Title of Class of Securities) -------------------------------------------------------------------------------- 051503100 -------------------------------------------------------------------------------- (CUSIP Number) with a copy to: Colin W. Dunn, Vice President and Treasurer Peter H. Ehrenberg, Esq. Bel Fuse Inc. Lowenstein Sandler PC 198 Van Vorst Street 65 Livingston Avenue Jersey City, New Jersey 07302 Roseland, New Jersey 07068 (201) 432-0463 (973) 597-2350 (Name, Address and Telephone Number of Persons Authorized to Receive Notices and Communications) September 2, 1999 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule l3g to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1) Names of Reporting Persons/I.R.S. Identification Nos. of Above Persons (entities only): Bel Fuse Inc. 22-1463699 2) Check the Appropriate Box if a Member of a Group (See Instructions): (a) [ ] (b) [ ] 3) SEC Use Only 4) Source of Funds (See Instructions): WC 5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e): [ ] 6) Citizenship or Place of Organization: New Jersey Number of 7) Sole Voting Power: 249,900 ----------------------------------- Shares Beneficially 8) Shared Voting Power: 0 ----------------------------------- Owned by Each Reporting 9) Sole Dispositive Power: 249,900 ----------------------------------- Person With: 10) Shared Dispositive Power: 0 ------------------------------------ 11) Aggregate Amount Beneficially Owned by Each Reporting Person: 249,900 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares: [ ] 13) Percent of Class Represented by Amount in Row (11): 5.7% 14) Type of Reporting Person (See Instructions): CO

Item 1. Security and Issuer. This statement on Schedule 13D (the "Schedule 13D") relates to the shares of Common Stock, no par value (the "Common Stock"), of Ault Incorporated (the "Company") whose principal executive offices are located at 7105 Northland Terrace, Minneapolis, Minnesota 55428-1028. Item 2. Identity and Background. Bel Fuse Inc. ("Bel Fuse") is a corporation organized under the laws of the State of New Jersey. Bel Fuse is engaged in the design, manufacture and sale of products used in networking, telecommunication, automotive and consumer electronic applications. Bel Fuse maintains its principal executive offices at 198 Van Vorst Street, Jersey City, New Jersey 07302. Attached is an appendix to Item 2 setting forth the name, present principal occupation or employment, the current business address and citizenship of each director and executive officer of Bel Fuse. Neither Bel Fuse nor, to the best of its knowledge, any of its directors or executive officers has ever been convicted in any criminal proceeding, nor has been a party to any civil proceeding commenced before a judicial or administrative body of competent jurisdiction as a result of which such entity or person was or is now subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration. In a series of transactions from August 17, 1999 through September 2, 1999, Bel Fuse, through its wholly-owned subsidiary, Bel Ventures Inc. ("Bel Ventures"), acquired an aggregate of 249,900 shares of Common Stock of the Company through open-market purchases. Bel Fuse paid an aggregate of approximately $1,353,396 (which amount includes the cost of commissions) for the shares of Common Stock of the Company out of the working capital of Bel Ventures. The respective dates of acquisition of the shares of Common Stock, the amount of shares of Common Stock purchased in each such acquisition, and the purchase price per share with respect to each such acquisition are set forth below: Date of Acquisition Number of Shares Purchased Price Per Share August 17, 1999 101,000 $5.125 August 18, 1999 40,500 $5.50 August 19, 1999 9,500 $5.50 August 20, 1999 11,500 $5.50 August 31, 1999 54,500 $5.625 September 2, 1999 32,900 $5.50 Item 4. Purpose of Transaction. Bel Fuse acquired the Common Stock for investment purposes, and except as described below, Bel Fuse has no present plans or intentions which relate to or would result in any of the transactions required to be described in Item 4 of Schedule 13D. Bel Fuse intends to closely evaluate the performance of the Common Stock, including, but not limited to, the continued analysis and assessment of the Company's business, assets, operations, financial condition, capital structure, management and prospects. Depending upon the Company's financial condition, results of operations, future prospects and other factors which Bel Fuse deems relevant, Bel Fuse may, and hereby reserves the right to, (i) acquire additional shares of Common Stock of the Company or sell the shares Bel Fuse owns, (ii) communicate with other shareholders of the Company or persons who may desire to become shareholders of the Company regarding the replacement of the Company's executive officers, members of the Board of Directors of the Company, and/or other matters regarding the management and operation of the Company, (iii) seek the removal of one or more members of the Company's Board of Directors and/or executive officers, (iv) seek to amend the Articles of Incorporation or By-laws of the Company to increase the size of the Board of Directors, elect one or more designees to fill any resulting vacancies, facilitate the removal of one or more directors and/or executive officers of the Company, and/or for any other purpose, (v) solicit proxies, to be used at either the Company's regular annual meeting or at a special meeting, or consents in lieu of any such meeting, for the purposes described in (iii) and/or (iv) above or for the election of one or more nominees of Bel Fuse and/or such other shareholders to the Board of Directors of the Company, (vi) seek to cause the Company to merge with or into, consolidate with, transfer all or substantially all of its assets to, or otherwise engage in any business combination with, one or more other parties (whether or not affiliated with or otherwise related to Bel Fuse), or (vii) take such other action as Bel Fuse may determine. Item 5. Interest in Securities of the Issuer. Based upon information set forth in the Company's Annual Report on Form 10-K for the fiscal year ended May 30, 1999, there were 4,383,787 shares of Common Stock issued and outstanding as of August 4, 1999. As of September 2, 1999, Bel Fuse beneficially owned an aggregate of 249,900 shares of Common Stock, or 5.7% of the issued and outstanding shares of Common Stock.

Bel Fuse has the sole power to vote or to direct the vote and the sole power to dispose or to direct the disposition of all 249,900 shares of Common Stock beneficially owned by it. Except as described in Item 3 of this Schedule 13D, during the past sixty days, there were no transactions in the shares of Common Stock, or securities convertible into or exchangeable for shares of Common Stock, by Bel Fuse or any person or entity controlled by Bel Fuse or any person or entity for which Bel Fuse possesses voting control over the securities thereof. No other person is known by Bel Fuse to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock beneficially owned by Bel Fuse. Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. No contracts, arrangements, understandings or similar relationships exist with respect to the securities of the Company between Bel Fuse and any person or entity. Item 7. Material to be Filed as Exhibits. None

Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. September 11, 1999 BEL FUSE INC. Name: Title: /s/colin W. Dunn Colin W. Dunn Vice President and Treasurer Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

APPENDIX TO ITEM 2 Name and Residence or Business Principal Employment and Address* Position with Bel Fuse Inc. Principal Business of Employer Elliot Bernstein** Executive Officer and Director Chairman of the Board and Chief Executive Officer of Bel Fuse Inc. Daniel Bernstein** Executive Officer and Director President of Bel Fuse Inc. Howard B. Bernstein*** Director Retired Colin W. Dunn** Executive Officer Vice President and Treasurer of Bel Fuse Inc. Arnold Sutta** Executive Officer Vice President of Sales of Bel Fuse Inc. Peter Christoffer** Executive Officer Vice President of Research and Development of Bel Fuse Inc. Joseph Meccariello** Executive Officer Vice President of Manufacturing of Bel Fuse Inc. John F. Tweedy**** Director Director of Public Relations of Globespan Semiconductor Inc. Robert H. Simandl***** Executive Officer and Director Secretary of Bel Fuse Inc. Peter Gilbert****** Director President and Chief Executive Officer of The Gilbert Manufacturing Company John S. Johnson******* Director Independent Consultant for various companies, including Bel Fuse Inc. * All of the directors and executive officers of Bel Fuse Inc. are citizens of the United States, except for Colin W. Dunn who is an Australian citizen. ** Business address is Bel Fuse Inc., 198 Van Vorst Street, Jersey City, New Jersey 07032. *** Residence is 21 Big Beech Lane, Colts Neck, New Jersey 07722. **** Business address is Globespan Semiconductor Inc., 100 Schulz Drive, Red Bank, New Jersey 07701. ***** Business address is 24 North 3rd Avenue, Highland Park, New Jersey 08904. ****** Business address is Gilbert Manufacturing Co., 1107 Broadway, Suite 1310, New York, New York 10010. ******* Residence is P.O. Box 1164, Queeche, Vermont 05059. End of Filing 2005 EDGAR Online, Inc.